
DHA RSV circular and AED 50 flu shots put respiratory vaccine season on UAE operators' agenda
Flu, Covid-19 and RSV vaccine demand is starting. UAE clinics need eligibility checks, stock plans and payer clarity.
How Zavis verifies this coverage
Editorial standards, source rules, methodology, and review provenance are public.
Respiratory virus season has begun, and UAE clinics should treat fall vaccination as an operational issue covering flu, Covid-19 and RSV, rather than a single flu-shot campaign.
The trigger is a fresh wave of international guidance on fall vaccines, including a 2 October 2026 Associated Press report on flu, Covid-19 and RSV vaccination in the United States. The UAE question is different. Operators in Dubai must follow Dubai Health Authority (DHA) circulars and facility rules, Abu Dhabi providers must track Department of Health Abu Dhabi (DOH) and Abu Dhabi Public Health Centre (ADPHC) guidance, and clinics in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain need to watch Ministry of Health and Prevention (MOHAP) and Emirates Health Services channels.
What changed for this season
Dubai has already moved on RSV. DHA issued circular CIR-2026-00000161 on 2 September 2026, addressed to all health professionals and facilities under its jurisdiction, on prevention and vaccination against respiratory syncytial virus. That matters for paediatrics, obstetrics, family medicine and emergency departments, where RSV demand can arrive before winter clinic capacity is staffed.
Abu Dhabi has also started earlier than usual. ADPHC said on 18 September 2026 that it had begun 2026-2027 seasonal flu preparations and started vaccinations at selected Majalis in Abu Dhabi, Al Ain and Al Dhafra. It reported more than 350,000 flu vaccinations during the 2025-2026 season through more than 130 healthcare facilities, 11 pharmacies and community sites.
“make prevention simple and accessible” — Abu Dhabi Public Health Centre, 18 September 2026
MOHAP lists the National Seasonal Flu Awareness Campaign as running from 1 September 2026 to 31 March 2027. For northern emirates operators, that is the practical planning window for staffing, patient reminders and procurement.
What clinics and insurers should price
Published UAE prices show a wide gap between public and private flu vaccine access. A Dubai government resolution lists the DHA seasonal influenza vaccine charge at AED 50. Current private offers visible in Dubai range roughly from AED 60 to AED 199, depending on whether consultation, home administration or paediatric review is included. Operators should avoid quoting one market price without specifying the service bundle.
- Flu: annual vaccination is the main volume service. Eligibility commonly starts at 6 months, with higher priority for children, pregnant women, older adults, healthcare workers and patients with chronic disease.
- Covid-19: eligibility and product availability should be checked against current DHA, DOH or MOHAP channels before booking campaigns. Do not rely on a US fall schedule for UAE consent forms.
- RSV: DHA has a 2026 RSV circular, while DOH guidance for infants includes single-dose long-acting monoclonal antibodies for eligible babies born during 1 September to 1 March.
- Payers: Daman, Thiqa, Sukoon and other insurers may treat preventive vaccination differently by plan. Clinics should confirm coding, prior approval and direct-billing rules before launching corporate or school drives.
The financial risk is small per dose and large in aggregate. A provider offering 5,000 flu vaccinations at AED 75 records AED 375,000 in gross vaccine revenue before consultation or home-care fees. The same campaign can also reduce pressure on urgent care if triage scripts, fever protocols and test ordering rules are consistent.
Where the UAE risk sits
Emergency-care operators should watch paediatric respiratory presentations first. RSV usually hits infants and older adults hardest, while flu increases outpatient, urgent-care and inpatient load. Covid-19 now behaves more like a recurring respiratory risk for operations, with staffing exposure and high-risk patient pathways still relevant.
For COOs, the immediate checklist is practical: verify vaccine supply, update consent forms, train call-centre staff on eligibility, and separate vaccine visits from symptomatic respiratory appointments. For CFOs, the work is payer mapping. For medical directors, the issue is liability: clinicians should document eligibility, contraindications, product name, batch number and regulator-consistent counselling.
Patients should be directed to licensed providers rather than informal vaccine listings. In Dubai, operators can cross-check facilities through the DHA medical registry. In Abu Dhabi, DOH lists licensed emergency departments and facility resources. For a cross-emirate search, readers can use the UAE Open Healthcare Directory to find licensed emergency care providers and nearby clinics before demand peaks.
Zavis Intelligence
Healthcare Industry Desk
Contributing to UAE healthcare industry coverage
Related coverage
FAQ
What is happening in UAE healthcare industry?
Flu, Covid-19 and RSV vaccine demand is starting. UAE clinics need eligibility checks, stock plans and payer clarity.



